-
Featured
Treatments for Benign Prostatic Hyperplasia
Current treatments generally focus on oral medications or invasive surgery, which can have side effects. The prostatic urethral lift and water steam therapy are effective, non-invasive treatments for BPH.
-
Featured
Multiparametric MRI/Ultrasound Fusion Biopsy Improves Prostate Cancer Detection
Active surveillance (AS) has become an accepted way to manage prostate cancer in men at lower risk. Multiparametric MRI can be used in conjunction with the standard transrectal ultrasound (TRUS)-guided biopsy to improve detection of clinically significant cancers.
-
Featured
BPH Supplements Have Little Support for Efficacy and Safety
To better advise patients about herbal remedies for prostate enlargement or benign prostatic hyperplasia (BPH), researchers scoured the scientific literature for evidence on every individual ingredient of every available supplement.
-
Transperineal Prostate Biopsy Feasible in Outpatient Practice
Douglas M. Dahl, MD, and colleagues reviewed their initial experience with in-office transperineal prostate biopsy. After 130 procedures, they noted no infectious complications and an antibiotic utilization rate of 48%.
-
Using Machine Learning to Predict Prostate Cancer Progression During Active Surveillance
Madhur Nayan, MDCM, PhD, and Adam S. Feldman, MD, MPH, and colleagues created the first machine learning models for predicting prostate cancer progression during active surveillance and found they outperformed traditional logistic regression.
-
Prostate Cancer Patients with Posterior Positive Surgical Margins Have Poorer Prognosis
Shulin Wu, MD, PhD, and Chin-Lee Wu, MD, PhD, of the Departments of Urology and Pathology, present evidence that prostate cancer patients who have posterior positive surgical margins (PSM) after radical prostatectomy have a more aggressive disease than those with anterior PSM.
Prostate Contributors
-
Adam Scott Feldman, MD, MPH
Director, Combined Harvard Urologic Oncology Fellowship, Director of Research and Urologic Oncologist, Department of Urology, Massachusetts General Hospital
Recent Article
Using Machine Learning to Predict Prostate Cancer Progression During Active Surveillance
-
Douglas Middleton Dahl, MD
Chief, Division of Urologic Oncology, Director of Robotic Surgery, Associate Professor, Harvard Medical School
Recent Article
Transperineal Prostate Biopsy Feasible in Outpatient Practice
-
-
Jason A. Efstathiou, MD, DPhil
Director, Genitourinary Service, Department of Radiation Oncology, Clinical Co-Director, The Claire and John Bertucci Center for Genitourinary Cancers Multidisciplinary Clinic
Recent Article
Gene Profiling of Bladder Tumors Shows Promise for Identifying Candidates for Trimodality Therapy -
Matthew F. Wszolek, MD
Chair of Quality and Safety, Department of Urology, Massachusetts General Hospital, Urological Oncologist, Mass General Cancer Center, Instructor in Surgery, Harvard Medical School
Recent Article
Advancing Trimodality Therapy for Bladder Cancer
-
Mukesh G. Harisinghani, MD
Director, Abdominal MRI, Department of Radiology, Massachusetts General Hospital
Recent Article
Review: Advances in Radiologic Staging of Colorectal Cancer
-
Shahin Tabatabaei, MD
Director, Prostate Health Program
Recent Article
BPH Supplements Have Little Support for Efficacy and Safety
Urology Care at Mass General
The Department of Urology at Massachusetts General Hospital offers sophisticated, compassionate care and the most innovative treatments for patients with any type of urological condition.Resource Links
